Valeant CEO: Allergan Holders Support Vote on Takeover Offer

Valeant Pharmaceuticals CEO Michael Pearson said the company is nearing its goal of rounding up enough support from Allergan shareholders to secure a vote on its $53 billion hostile bid.



from WSJ.com: US Business http://ift.tt/1l8ekh6

via IFTTT